Endocrine & Metabolic Disease

PSI is a leading full-service CRO operating globally.

98% of PSI-managed clinical trials complete patient enrollment on or ahead of schedule.

PSI's exceptional repeat and referral business rate distinguishes PSI in the market place as a "no-nonsense" CRO that delivers across trials of all sizes and levels of complexity.

PSI has successfully performed Phase II/III studies in the following endocrine and metabolic disease indications:

  • Contraception
  • Diabetes mellitus (adult, paediatric)
    • Type I
    • Type II
  • Diabetic nephropathy
  • Diabetic neuropathy
  • Diabetic retinopathy
  • Growth retardation
  • Hyperlipidemia
  • Metabolic syndrome
  • Obesity
  • Osteoporosis

PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including internists, gynecologists, and endocrinologists.




For more information, please contact us:

For North America Clients:

Ginny Payeur
Tel: +1 650 592 91 01
Fax: +1 650 592 91 09
E-mail: Ginny.Payeur@psi-cro.com		 For European, Japanese and ROW Clients:

Olga Alfonsova
Tel: +7 812 320 38 20
Fax: +7 812 320 38 50
E-mail: Olga.Alfonsova@psi-cro.com